Medicare Enrolled
Dr. Sarah Coleman, MD
Rheumatology · Willow Grove, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Coleman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Coleman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Coleman
Dr. Sarah Coleman is a rheumatology specialist in Willow Grove, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Coleman performed 215,461 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Coleman received a total of $8,322 from 35 pharmaceutical and/or device companies across 474 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Coleman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 3% volume in PA
$8,322 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗215,461
Medicare services
Top 3% in PA for rheumatology
Not available
Unique patients (not deduplicated)
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 78,520 | $5 | $7 |
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
41,200 | $4 | $10 |
| Denosumab injection (Prolia/Xgeva) | 23,640 | $18 | $27 |
| Romosozumab injection (Evenity) for osteoporosis | 22,470 | $8 | $20 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
21,050 | $11 | $45 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
10,600 | $34 | $75 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
6,100 | $26 | $130 |
| Privigen immune globulin injection, 500 mg An intravenous injection of Privigen, a non-lyophilized immune globulin product, administered in a 500 mg dose. |
5,090 | $37 | $110 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
1,950 | $64 | $165 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
849 | $98 | $240 |
| Joint lubricant injection (Synvisc) | 816 | $7 | $35 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
809 | $63 | $240 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
642 | $1 | $12 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
502 | $113 | $688 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
192 | $63 | $158 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
191 | $24 | $245 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
171 | $54 | $311 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
165 | $17 | $100 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
124 | $65 | $273 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
110 | $6 | $215 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
75 | $125 | $372 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
62 | $48 | $179 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
50 | $13 | $109 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
47 | $4 | $14 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
36 | $1 | $5 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
17.9% high complexity
81.6% medium
0.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,322
Total received (2018-2024)
Avg $1,189/year across 7 years
Top 33% in PA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
474
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,656
2023
$1,748
2022
$580
2021
$233
2020
$362
2019
$1,827
2018
$916
Payments by company (2024)
Amgen Inc.
$723
AstraZeneca Pharmaceuticals LP
$450
E.R. Squibb & Sons, L.L.C.
$325
ABBVIE INC.
$189
Novartis Pharmaceuticals Corporation
$163
UCB, Inc.
$113
Janssen Biotech, Inc.
$101
ANI Pharmaceuticals, Inc.
$96
Organon Llc
$69
Radius Health, Inc.
$59
Genentech USA, Inc.
$57
Kyowa Kirin, Inc.
$56
PFIZER INC.
$54
GlaxoSmithKline, LLC.
$50
Kiniksa Pharmaceuticals International, plc
$35
Sandoz Inc.
$33
Alexion Pharmaceuticals, Inc.
$30
Mallinckrodt Hospital Products Inc.
$21
QIAGEN, LLC
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Top 3 companies account for 56.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,006
Novartis Pharmaceuticals Corporation
$609
AbbVie, Inc.
$544
AstraZeneca Pharmaceuticals LP
$521
E.R. Squibb & Sons, L.L.C.
$484
UCB, Inc.
$459
PFIZER INC.
$401
Flexion Therapeutics, Inc.
$386
AbbVie Inc.
$364
Lilly USA, LLC
$356
ABBVIE INC.
$353
Janssen Biotech, Inc.
$321
Radius Health, Inc.
$192
GENZYME CORPORATION
$182
Genentech USA, Inc.
$175
GlaxoSmithKline, LLC.
$167
ANI Pharmaceuticals, Inc.
$125
Aurinia Pharma U.S., Inc.
$74
Organon Llc
$69
Horizon Therapeutics plc
$68
Organon LLC
$60
EMD Serono, Inc.
$59
Kyowa Kirin, Inc.
$56
Alexion Pharmaceuticals, Inc.
$46
Kiniksa Pharmaceuticals International, plc
$35
Sandoz Inc.
$33
Fidia Pharma USA Inc.
$27
Sobi, Inc
$26
Mallinckrodt Hospital Products Inc.
$21
Encore Dermatology Inc.
$20
Bioventus LLC
$19
Fresenius Kabi USA, LLC
$17
QIAGEN, LLC
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Ironwood Pharmaceuticals, Inc
$14
Top 3 companies account for 38.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUZALLO · Durolane · EVENITY · Enbrel · FORTEO · HADLIMA · HUMIRA · HYMOVIS · HYRIMOZ · Humira · IDACIO · ILARIS · Impoyz · KEVZARA · KRYSTEXXA · Kineret · LUPKYNIS · Mavenclad · ORENCIA · Otezla · PURIFIED CORTROPHIN GEL · Prolia · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tymlos · XELJANZ · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
179
County median income
$111,521
Nearest hospital to ZIP centroid (approximate)
JEFFERSON ABINGTON HOSPITAL
1.5 mi
1.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Coleman is a mixed practice specialist, with above-average Medicare volume (top 3% in PA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Coleman experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Coleman performed 78,520 tocilizumab injection (actemra) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Coleman receive payments from pharmaceutical companies?
Yes. Dr. Coleman received a total of $8,322 from 35 companies across 474 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Coleman's costs compare to other rheumatologists in Willow Grove?
Dr. Coleman's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Coleman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Willow Grove
Browse rheumatologists in Willow Grove ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in PA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in PA
Which PA rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology